1 |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315 (8): 801-810.
|
2 |
Angus DC, Van der Poll T. Severe sepsis and septic shock[J]. N Eng J Med, 2013, 369 (9): 840-851.
|
3 |
Fleischmann C, Scherag A, Adhikari NK, et al. Asse-ssment of global incidence and mortality of hospital-treated sepsis: current estimates and limitations[J]. Am J Respir Crit Care Med, 2016, 193 (3): 259-272.
|
4 |
Eissa D, Carton EG, Buggy DJ. Anaesthetic manage-ment of patients with severe sepsis[J]. Br J Anaesth, 2010, 105 (6): 734-743.
|
5 |
Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure[J]. Chest, 1992, 101 (6): 1481-1483.
|
6 |
Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference[J]. Crit Care Med, 2003, 31 (4): 1250-1256.
|
7 |
Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J]. Crit Care Med, 2004, 32 (3): 858-873.
|
8 |
Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008[J]. Crit Care Med, 2008, 36 (1): 296-327.
|
9 |
Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012[J]. Intensive Care Med, 2013, 39 (2): 165-228.
|
10 |
Chen JP, Fang XM, Jin XJ, et al. Expert consensus on the perioperative management of patients with sepsis[J]. World J Emerg Med, 2015, 6 (4): 245-260.
|
11 |
Van der Poll T, Van de Veerdonk FL, Scicluna BP, et al. The immunopathology of sepsis and potential therapeutic targets[J]. Nat Rev Immunol, 2017, 17 (7): 407-420.
|
12 |
Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients[J]. Crit Care Med, 2008, 36 (12): 3190-3197.
|
13 |
NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients[J]. N Engl J Med, 2009, 360 (13): 1283-1297.
|